Oncolytics Biotech Inc. (ONCY)

NASDAQ: ONCY · IEX Real-Time Price · USD

0.990

-0.005 (-0.52%)

At close: Jul 2, 2024, 4:00 PM

1.020

+0.030 (3.03%)

After-hours: Jul 2, 2024, 6:01 PM EDT

Oncolytics Biotech Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2000
Selling, General & Admin	16.08	11.49	13.32	12.51	9.56	Upgrade
Research & Development	17.71	15.43	12.92	12.95	10.82	Upgrade
Operating Expenses	33.79	26.92	26.24	25.46	20.38	Upgrade
Operating Income	-33.79	-26.92	-26.24	-25.46	-20.38	Upgrade
Other Expense / Income	-6.14	-2.17	0.02	-2.95	12.75	Upgrade
Pretax Income	-27.66	-24.75	-26.26	-22.51	-33.12	Upgrade
Income Tax	0.1	0.08	0.05	0	0	Upgrade
Net Income	-27.75	-24.84	-26.3	-22.51	-33.12	Upgrade
Shares Outstanding (Basic)	68	58	54	40	22	Upgrade
Shares Outstanding (Diluted)	68	58	54	40	22	Upgrade
Shares Change	16.53%	8.44%	32.66%	82.22%	38.22%	Upgrade
EPS (Basic)	-0.41	-0.43	-0.49	-0.56	-1.50	Upgrade
EPS (Diluted)	-0.41	-0.43	-0.49	-0.56	-1.50	Upgrade
Free Cash Flow	-28.46	-23.41	-22.72	-22.1	-19.92	Upgrade
Free Cash Flow Per Share	-0.42	-0.40	-0.42	-0.55	-0.90	Upgrade
EBITDA	-27.25	-24.36	-25.8	-22.06	-32.64	Upgrade
Depreciation & Amortization	0.4	0.39	0.45	0.45	0.49	Upgrade
EBIT	-27.66	-24.75	-26.26	-22.51	-33.12	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).